1-(10H-phenothiazin-10-yl)-3-(5H-pyrido[4,3-b]indol-5-yl)propan-1-one

ID: ALA4848411

PubChem CID: 164613856

Max Phase: Preclinical

Molecular Formula: C26H19N3OS

Molecular Weight: 421.53

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CCn1c2ccccc2c2cnccc21)N1c2ccccc2Sc2ccccc21

Standard InChI:  InChI=1S/C26H19N3OS/c30-26(29-22-9-3-5-11-24(22)31-25-12-6-4-10-23(25)29)14-16-28-20-8-2-1-7-18(20)19-17-27-15-13-21(19)28/h1-13,15,17H,14,16H2

Standard InChI Key:  FYRFGJSXHGSSRA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 36  0  0  0  0  0  0  0  0999 V2000
   22.9717  -26.7733    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   22.9717  -25.1389    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.6770  -25.5517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6754  -26.3671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3796  -26.7743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0859  -26.3674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0835  -25.5489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3787  -25.1453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2664  -26.3689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2689  -25.5535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5652  -25.1454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8584  -25.5515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8598  -26.3700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5642  -26.7744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9703  -24.3218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6772  -23.9119    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.2618  -23.9144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2604  -23.0972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5520  -22.6899    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.8038  -23.0279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2575  -22.4205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4603  -22.5905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2084  -23.3674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7598  -23.9744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5549  -23.8013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6586  -21.7160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4591  -21.8823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0014  -21.2729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7444  -20.4970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9400  -20.3339    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.4012  -20.9447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 10  2  1  0
  9  1  1  0
  1  4  1  0
  3  2  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  2 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 27  1  0
 26 21  1  0
 20 19  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4848411

    ---

Associated Targets(Human)

GRIN1 Tclin Glutamate NMDA receptor; GRIN1/GRIN2A (719 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Chrna3 Nicotinic acetylcholine receptor alpha6/alpha3/beta4 (315 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Cholinesterase (8742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 421.53Molecular Weight (Monoisotopic): 421.1249AlogP: 6.41#Rotatable Bonds: 3
Polar Surface Area: 38.13Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.03CX LogP: 4.98CX LogD: 4.42
Aromatic Rings: 5Heavy Atoms: 31QED Weighted: 0.34Np Likeness Score: -0.99

References

1. Schwarthoff S, Tischer N, Sager H, Schätz B, Rohrbach MM, Raztsou I, Robaa D, Gaube F, Arndt HD, Winckler T..  (2021)  Evaluation of γ-carboline-phenothiazine conjugates as simultaneous NMDA receptor blockers and cholinesterase inhibitors.,  46  [PMID:34391122] [10.1016/j.bmc.2021.116355]

Source